| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
1 company
Robert Andrade is Chief Financial Officer at FENC. Robert Andrade's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.7M at current prices.
Our model assigns Robert Andrade a middling insider score of 69/100, based on 11 past trades. Over a 12-month horizon, 63.6% of those trades were profitable, with an average 12-month return of +14.3%.
The FENC filings lean toward selling, a net 167,450 shares.
Robert Andrade has 58 Form 4 filings on record from February 2018 to October 2026, all as Chief Financial Officer at Fennec Pharmaceuticals (FENC), 2018–2026.
The 78 reported transactions were 32 stock awards, 16 option exercises, 13 option or other derivative awards and 11 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 6 sales worth about $1.9M.
The largest open-market sale was 75,000 shares of FENC at an average $11.78 on August 27, 2026, about $884K.
4 of the 5 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other was not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | FENC Fennec Pharmaceuticals Inc. | Chief Financial Officer | Sale+OE10b5-1 | 75,000 | $11.78 | $883,500.00 | -25.6% | - | - | |
| Apr 1, 2024 | FENC Fennec Pharmaceuticals Inc. | Chief Financial Officer | Buy | 12,500 | $0.00 | - | +13.6% | -42.2% | -49.0% | |
| Mar 26, 2024 | FENC Fennec Pharmaceuticals Inc. | Chief Financial Officer | Sell | 13,975 | $10.90 | $152,345.67 | -13.2% | -41.7% | -40.6% | |
| Mar 25, 2024 | FENC Fennec Pharmaceuticals Inc. | Chief Financial Officer | Sell10b5-1 | 13,975 | $11.00 | $153,690.06 | -11.7% | -42.3% | -41.5% | |
| Jan 5, 2024 | FENC Fennec Pharmaceuticals Inc. | Chief Financial Officer | Sell10b5-1 | 30,000 | $10.53 | $315,750.00 | -20.0% | +5.4% | -40.6% | |
| Jun 30, 2023 | FENC Fennec Pharmaceuticals Inc. | Chief Financial Officer | Sale+OE10b5-1 | 25,000 | $8.93 | $223,325.00 | -16.7% | -19.0% | -30.8% | |
| Dec 30, 2022 | FENC Fennec Pharmaceuticals Inc. | Chief Financial Officer | Sell | 22,000 | $9.60 | $211,288.00 | -12.8% | -10.9% | +16.9% |